You are here

Article info

Article menu

Download PDFPDF

Case report
Does withdrawal of immunosuppression in rheumatoid arthritis after SARS-CoV-2 infection increase the risk of vasculitis?
Free

Authors

  1. Correspondence to Dr Sukhraj Singh; sukhraj.singh{at}jax.ufl.edu
View Full Text

Citation

Singh S, Vaghaiwalla Z, Thway M, et al
Does withdrawal of immunosuppression in rheumatoid arthritis after SARS-CoV-2 infection increase the risk of vasculitis?
BMJ Case Reports CP 2021;14:e241125.

Publication history

  • Accepted March 25, 2021
  • First published April 12, 2021.
Online issue publication 
April 12, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© BMJ Publishing Group Limited 2021. No commercial re-use. See rights and permissions. Published by BMJ. This article is made freely available for use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.https://bmj.com/coronavirus/usage